Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
BTIG analyst Ryan Zimmerman upgraded GE HealthCare stock to Buy from Hold. His new price target is $100, implying about 15% upside.
GE HealthCare's stock is ending a good week on a bad note on Friday, after its former parent, now known as GE Aerospace, took advantage of the recent rally to sell off about one half of its remaining stake.
GE Healthcare (NASDAQ: GEHC) stock price has bounced back in the past few months, helped by the overall recovery of American equities and the view that it is a bargain company. It rose to a high of $88.51 on Thursday, its highest level since April 29th.
GEHC launches AI-enhanced ultrasound and ECG-less Cardiac CT technologies, offering rapid, accurate cardiac diagnostics at the point of care.
GE HealthCare's (GEHC) latest collaboration is likely to equip clinicians with a toolset to deliver enhanced care to female patients and improve the patient experience.
GE HealthCare's Q2 earnings were disappointing, with revenue stagnating and cost efficiencies driving earnings, leading to a lowered price target and sell rating. The company continues to lag behind the market in various healthcare sectors, with AI potential diminishing and a decreased focus on R&D. Upside potential lies in the healthcare market and AI technology, but GEHC's slow progress and competition pose challenges for future growth.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GE HealthCare's (GEHC) second-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
GE HealthCare (GEHC) shares rose over 4% in early trading Wednesday after the company reported second-quarter profits that beat analysts' estimates.
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.92 per share a year ago.